What is Autonomize?
Autonomize operates at the intersection of healthcare and artificial intelligence, focusing on enhancing enterprise operations. The company's platform is designed to structure complex, unstructured healthcare data, thereby supporting evidence-based decision-making and orchestrating critical workflows. By leveraging healthcare-native AI agents in conjunction with human expertise, Autonomize aims to streamline operations and improve outcomes. Its core competency lies in healthcare software, with a strong secondary alignment to business intelligence software due to its emphasis on providing actionable intelligence, robust decision support, and operational insights for healthcare organizations.
How much funding has Autonomize raised?
Autonomize has raised a total of $32M across 2 funding rounds:
Angel/Seed
$4M
Series A
$28M
Angel/Seed (2023): $4M with participation from The Next Practices Group
Series A (2025): $28M led by Tau Ventures, Valtruis, Cigna, ATX Venture Partners, and Asset Management
Key Investors in Autonomize
Tau Ventures
Tau Ventures is an AI-first, early-stage venture fund that focuses on healthcare, enterprise, and automation, investing primarily at the seed stage and selectively in Series A and beyond. They leverage deep sector expertise to accelerate the growth of mission-critical technologies.
Valtruis
Valtruis provides a platform that invests in and partners with leaders to transform healthcare through value-based care, focusing on revolutionizing how care is accessed, delivered, experienced, and paid for.
Cigna
The Cigna Group is a global health company committed to improving health and vitality through its Cigna Healthcare and Evernorth Health Services divisions.
What's next for Autonomize?
With the recent major strategic investment, Autonomize is poised for significant expansion and further development of its AI-powered healthcare solutions. The substantial capital injection, totaling $32M with a recent $28M round, signals strong investor confidence in the company's trajectory and its potential to disrupt the healthcare technology landscape. This funding will likely fuel advancements in its AI agent technology, enhance data structuring capabilities, and broaden its market reach. Autonomize is strategically positioned to capitalize on the growing demand for intelligent automation and data-driven decision support within the healthcare industry, aiming to solidify its leadership in enterprise healthcare operations.
See full Autonomize company page
